CagriSema is a combination of amylin (cagrilintide) and glucagon-like peptide-1 (semaglutide) analogues being developed for weight management. We quantified CagriSema’s action on energy intake and exp
Abstract: Introduction: One of the major challenges in evaluating medical education is measuring practical skills, crossing the limits of theoretical knowledge. The Objective Structured Clinical Exami
